|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
7 December 2015 |
|
Main ID: |
NCT00220077 |
|
Date of registration:
|
19/09/2005 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Determination of the Role of Microarray for Prognosis and Prediction to Chemotherapy Sensitivity in Patients With Operable, Locally Advanced and Metastatic Oesophageal Cancer
|
|
Scientific title:
|
Determination of the Role of Microarray for Prognosis and Prediction to Chemotherapy Sensitivity in Patients With Operable, Locally Advanced and Metastatic Oesophageal Cancer |
|
Date of first enrolment:
|
June 2002 |
|
Target sample size:
|
400 |
|
Recruitment status: |
Recruiting |
|
URL:
|
https://clinicaltrials.gov/show/NCT00220077 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
United Kingdom
| | | | | | | |
|
Contacts
|
|
Name:
|
David Cunningham |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Royal Marsden NHS Foundation Trust |
|
|
Name:
|
Sheela Rao |
|
Address:
|
|
|
Telephone:
|
0208 642 6011 |
|
Email:
|
sheela.rao@rmh.nhs.uk |
|
Affiliation:
|
|
|
|
Name:
|
Sheela Rao |
|
Address:
|
|
|
Telephone:
|
0208 642 6011 |
|
Email:
|
sheela.rao@rmh.nhs.uk |
|
Affiliation:
|
|
|
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Any patient with histologically proven operable ,locally advanced and metastatic
oesophageal or gastric carcinoma.
Exclusion Criteria:
- Second malignancy
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Oesophageal Cancer
|
|
Intervention(s)
|
|
Procedure: Endoscopy
|
|
Primary Outcome(s)
|
|
To determine whether specific gene expression profiles are associated with response in oesophago-gastric cancer.
|
|
Secondary Outcome(s)
|
|
Evaluation of the association of gene expression profiling and progression free survival and overall survival in patients with oesophago-gastric cancer.
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|